nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP2C19—Sorafenib—thyroid cancer	0.227	0.286	CbGbCtD
Ramelteon—CYP1A2—Sorafenib—thyroid cancer	0.21	0.264	CbGbCtD
Ramelteon—CYP3A4—Vandetanib—thyroid cancer	0.182	0.229	CbGbCtD
Ramelteon—CYP3A4—Sorafenib—thyroid cancer	0.11	0.138	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—thyroid cancer	0.0667	0.0838	CbGbCtD
Ramelteon—MTNR1A—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00547	0.0448	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00547	0.0448	CbGpPWpGaD
Ramelteon—Influenza—Vandetanib—thyroid cancer	0.00478	0.0585	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00445	0.0543	CcSEcCtD
Ramelteon—Depression—Vandetanib—thyroid cancer	0.00425	0.052	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CALCB—thyroid cancer	0.00407	0.0333	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CALCB—thyroid cancer	0.00407	0.0333	CbGpPWpGaD
Ramelteon—Dysgeusia—Vandetanib—thyroid cancer	0.00326	0.0399	CcSEcCtD
Ramelteon—Arthralgia—Vandetanib—thyroid cancer	0.00284	0.0347	CcSEcCtD
Ramelteon—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00273	0.0223	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00248	0.0303	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00248	0.0202	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00248	0.0202	CbGpPWpGaD
Ramelteon—Insomnia—Vandetanib—thyroid cancer	0.00246	0.0301	CcSEcCtD
Ramelteon—MTNR1A—G alpha (i) signalling events—SST—thyroid cancer	0.00242	0.0198	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—SST—thyroid cancer	0.00242	0.0198	CbGpPWpGaD
Ramelteon—Fatigue—Vandetanib—thyroid cancer	0.00235	0.0287	CcSEcCtD
Ramelteon—MTNR1B—GPCR downstream signaling—CALCB—thyroid cancer	0.0023	0.0188	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CALCB—thyroid cancer	0.0023	0.0188	CbGpPWpGaD
Ramelteon—Dysgeusia—Sorafenib—thyroid cancer	0.0022	0.0269	CcSEcCtD
Ramelteon—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00215	0.0175	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00212	0.0174	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CALCB—thyroid cancer	0.00209	0.0171	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CALCB—thyroid cancer	0.00209	0.0171	CbGpPWpGaD
Ramelteon—Thinking abnormal—Epirubicin—thyroid cancer	0.00208	0.0254	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00208	0.017	CbGpPWpGaD
Ramelteon—Asthenia—Vandetanib—thyroid cancer	0.00195	0.0238	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00192	0.0157	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00192	0.0157	CbGpPWpGaD
Ramelteon—Thinking abnormal—Doxorubicin—thyroid cancer	0.00192	0.0235	CcSEcCtD
Ramelteon—Arthralgia—Sorafenib—thyroid cancer	0.00191	0.0234	CcSEcCtD
Ramelteon—Myalgia—Sorafenib—thyroid cancer	0.00191	0.0234	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—TSHR—thyroid cancer	0.00188	0.0154	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—TSHR—thyroid cancer	0.00188	0.0154	CbGpPWpGaD
Ramelteon—Diarrhoea—Vandetanib—thyroid cancer	0.00186	0.0227	CcSEcCtD
Ramelteon—Anaphylactic shock—Sorafenib—thyroid cancer	0.00184	0.0224	CcSEcCtD
Ramelteon—Dizziness—Vandetanib—thyroid cancer	0.0018	0.022	CcSEcCtD
Ramelteon—Headache—Vandetanib—thyroid cancer	0.0017	0.0208	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00167	0.0204	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—thyroid cancer	0.00165	0.0202	CcSEcCtD
Ramelteon—Nausea—Vandetanib—thyroid cancer	0.00162	0.0197	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—PTCH1—thyroid cancer	0.0016	0.0131	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—PTCH1—thyroid cancer	0.0016	0.0131	CbGpPWpGaD
Ramelteon—Fatigue—Sorafenib—thyroid cancer	0.00158	0.0193	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—thyroid cancer	0.00153	0.0187	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—SST—thyroid cancer	0.00147	0.012	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—SST—thyroid cancer	0.00147	0.012	CbGpPWpGaD
Ramelteon—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00143	0.0174	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CALCA—thyroid cancer	0.00141	0.0115	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CALCA—thyroid cancer	0.00141	0.0115	CbGpPWpGaD
Ramelteon—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00141	0.0115	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—PPARG—thyroid cancer	0.0014	0.0115	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—PPARG—thyroid cancer	0.0014	0.0115	CbGpPWpGaD
Ramelteon—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00132	0.0161	CcSEcCtD
Ramelteon—Asthenia—Sorafenib—thyroid cancer	0.00132	0.0161	CcSEcCtD
Ramelteon—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00128	0.0105	CbGpPWpGaD
Ramelteon—Diarrhoea—Sorafenib—thyroid cancer	0.00126	0.0153	CcSEcCtD
Ramelteon—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00124	0.0102	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CALCB—thyroid cancer	0.00123	0.0101	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CALCB—thyroid cancer	0.00123	0.0101	CbGpPWpGaD
Ramelteon—Dizziness—Sorafenib—thyroid cancer	0.00121	0.0148	CcSEcCtD
Ramelteon—Influenza—Epirubicin—thyroid cancer	0.00119	0.0146	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—TRIM33—thyroid cancer	0.00117	0.00957	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TRIM33—thyroid cancer	0.00117	0.00957	CbGpPWpGaD
Ramelteon—Headache—Sorafenib—thyroid cancer	0.00115	0.014	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00111	0.0135	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—thyroid cancer	0.0011	0.0135	CcSEcCtD
Ramelteon—Nausea—Sorafenib—thyroid cancer	0.00109	0.0133	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—TSHR—thyroid cancer	0.00107	0.00871	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—TSHR—thyroid cancer	0.00107	0.00871	CbGpPWpGaD
Ramelteon—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00103	0.0125	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—TSHR—thyroid cancer	0.000967	0.00791	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TSHR—thyroid cancer	0.000967	0.00791	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000967	0.00791	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—PTEN—thyroid cancer	0.000961	0.00786	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—PTEN—thyroid cancer	0.000961	0.00786	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000952	0.00778	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000952	0.00778	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000851	0.00696	CbGpPWpGaD
Ramelteon—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000846	0.00692	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—SST—thyroid cancer	0.000828	0.00678	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—SST—thyroid cancer	0.000828	0.00678	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PTCH1—thyroid cancer	0.000822	0.00673	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PTCH1—thyroid cancer	0.000822	0.00673	CbGpPWpGaD
Ramelteon—Dysgeusia—Epirubicin—thyroid cancer	0.000814	0.00994	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—CALCA—thyroid cancer	0.000797	0.00652	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CALCA—thyroid cancer	0.000797	0.00652	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TCF7L1—thyroid cancer	0.000781	0.00639	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TCF7L1—thyroid cancer	0.000781	0.00639	CbGpPWpGaD
Ramelteon—Dysgeusia—Doxorubicin—thyroid cancer	0.000753	0.0092	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—SST—thyroid cancer	0.000752	0.00615	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—SST—thyroid cancer	0.000752	0.00615	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000746	0.0061	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CALCA—thyroid cancer	0.000724	0.00592	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CALCA—thyroid cancer	0.000724	0.00592	CbGpPWpGaD
Ramelteon—Myalgia—Epirubicin—thyroid cancer	0.000707	0.00864	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—thyroid cancer	0.000707	0.00864	CcSEcCtD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00069	0.00564	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Epirubicin—thyroid cancer	0.000678	0.00829	CcSEcCtD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000663	0.00542	CbGpPWpGaD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000659	0.00539	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—thyroid cancer	0.000656	0.00537	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—thyroid cancer	0.000656	0.00537	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CDK1—thyroid cancer	0.000655	0.00536	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CDK1—thyroid cancer	0.000655	0.00536	CbGpPWpGaD
Ramelteon—Arthralgia—Doxorubicin—thyroid cancer	0.000655	0.008	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—thyroid cancer	0.000655	0.008	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000628	0.00767	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000618	0.00755	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—thyroid cancer	0.000613	0.0075	CcSEcCtD
Ramelteon—Somnolence—Epirubicin—thyroid cancer	0.000603	0.00737	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—thyroid cancer	0.000585	0.00714	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000572	0.00699	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—TSHR—thyroid cancer	0.000571	0.00467	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TSHR—thyroid cancer	0.000571	0.00467	CbGpPWpGaD
Ramelteon—Insomnia—Doxorubicin—thyroid cancer	0.000568	0.00694	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000562	0.0046	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000562	0.0046	CbGpPWpGaD
Ramelteon—Somnolence—Doxorubicin—thyroid cancer	0.000558	0.00682	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—thyroid cancer	0.000541	0.00661	CcSEcCtD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000537	0.0044	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MEN1—thyroid cancer	0.000537	0.0044	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MEN1—thyroid cancer	0.000537	0.0044	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000512	0.00419	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000509	0.00416	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000489	0.004	CbGpPWpGaD
Ramelteon—Asthenia—Epirubicin—thyroid cancer	0.000487	0.00595	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—PTCH1—thyroid cancer	0.000486	0.00397	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTCH1—thyroid cancer	0.000486	0.00397	CbGpPWpGaD
Ramelteon—Diarrhoea—Epirubicin—thyroid cancer	0.000464	0.00567	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—thyroid cancer	0.00045	0.0055	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—thyroid cancer	0.000448	0.00548	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—SST—thyroid cancer	0.000444	0.00364	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SST—thyroid cancer	0.000444	0.00364	CbGpPWpGaD
Ramelteon—Diarrhoea—Doxorubicin—thyroid cancer	0.000429	0.00525	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CALCA—thyroid cancer	0.000428	0.0035	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CALCA—thyroid cancer	0.000428	0.0035	CbGpPWpGaD
Ramelteon—Headache—Epirubicin—thyroid cancer	0.000425	0.00519	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—thyroid cancer	0.000415	0.00507	CcSEcCtD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000415	0.00339	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000407	0.00333	CbGpPWpGaD
Ramelteon—Nausea—Epirubicin—thyroid cancer	0.000403	0.00492	CcSEcCtD
Ramelteon—Headache—Doxorubicin—thyroid cancer	0.000393	0.0048	CcSEcCtD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000389	0.00319	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDK1—thyroid cancer	0.000387	0.00317	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDK1—thyroid cancer	0.000387	0.00317	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000381	0.00312	CbGpPWpGaD
Ramelteon—Nausea—Doxorubicin—thyroid cancer	0.000373	0.00455	CcSEcCtD
Ramelteon—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000366	0.003	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000317	0.00259	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRG1—thyroid cancer	0.000311	0.00254	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRG1—thyroid cancer	0.000311	0.00254	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000303	0.00248	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000285	0.00234	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TERT—thyroid cancer	0.000279	0.00228	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TERT—thyroid cancer	0.000279	0.00228	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000273	0.00223	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000269	0.0022	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HIF1A—thyroid cancer	0.000267	0.00218	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HIF1A—thyroid cancer	0.000267	0.00218	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—NRAS—thyroid cancer	0.000235	0.00192	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—NRAS—thyroid cancer	0.000235	0.00192	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000232	0.0019	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000229	0.00187	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—BRAF—thyroid cancer	0.000221	0.00181	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—BRAF—thyroid cancer	0.000221	0.00181	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.00022	0.0018	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000215	0.00176	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.00021	0.00172	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—KRAS—thyroid cancer	0.000202	0.00166	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—KRAS—thyroid cancer	0.000202	0.00166	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000178	0.00146	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000173	0.00142	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRAS—thyroid cancer	0.000172	0.00141	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRAS—thyroid cancer	0.000172	0.00141	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CHST14—thyroid cancer	0.000168	0.00137	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AKT1—thyroid cancer	0.000167	0.00137	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AKT1—thyroid cancer	0.000167	0.00137	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000162	0.00132	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—thyroid cancer	0.000161	0.00132	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—thyroid cancer	0.000161	0.00132	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—thyroid cancer	0.000156	0.00127	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—thyroid cancer	0.000156	0.00127	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AKT1—thyroid cancer	0.000152	0.00124	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AKT1—thyroid cancer	0.000152	0.00124	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000141	0.00115	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRAS—thyroid cancer	0.000139	0.00114	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRAS—thyroid cancer	0.000139	0.00114	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000138	0.00113	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HPGD—thyroid cancer	0.000135	0.00111	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CHST14—thyroid cancer	0.000129	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—thyroid cancer	0.00012	0.000978	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—thyroid cancer	0.00012	0.000978	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00011	0.000897	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—thyroid cancer	0.000106	0.000869	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—thyroid cancer	0.000106	0.000869	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPGD—thyroid cancer	0.000104	0.000853	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—thyroid cancer	0.000102	0.000831	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—thyroid cancer	0.000102	0.000831	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TPR—thyroid cancer	9.96e-05	0.000815	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	9.8e-05	0.000802	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—thyroid cancer	8.97e-05	0.000734	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—thyroid cancer	8.97e-05	0.000734	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.88e-05	0.000727	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TPR—thyroid cancer	7.76e-05	0.000635	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	7.64e-05	0.000625	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—thyroid cancer	7.46e-05	0.00061	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.99e-05	0.000572	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.92e-05	0.000566	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—RXRA—thyroid cancer	6.27e-05	0.000513	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.09e-05	0.000499	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TPR—thyroid cancer	5.99e-05	0.00049	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.89e-05	0.000482	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—thyroid cancer	5.81e-05	0.000475	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.44e-05	0.000445	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—RXRA—thyroid cancer	4.88e-05	0.000399	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.75e-05	0.000388	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.48e-05	0.000367	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARG—thyroid cancer	3.96e-05	0.000324	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—RXRA—thyroid cancer	3.77e-05	0.000308	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.11e-05	0.000255	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARG—thyroid cancer	3.08e-05	0.000252	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—thyroid cancer	2.71e-05	0.000222	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.42e-05	0.000198	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARG—thyroid cancer	2.38e-05	0.000195	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—thyroid cancer	2.11e-05	0.000173	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.87e-05	0.000153	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—thyroid cancer	1.63e-05	0.000134	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—thyroid cancer	1.56e-05	0.000128	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—thyroid cancer	1.22e-05	9.97e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—thyroid cancer	9.41e-06	7.69e-05	CbGpPWpGaD
